Please login to the form below

Not currently logged in
Email:
Password:

asthma

This page shows the latest asthma news and features for those working in and with pharma, biotech and healthcare.

FDA rejects GSK’s Nucala for COPD

FDA rejects GSK’s Nucala for COPD

There was bad if not unexpected news for GlaxoSmithKline late Friday, after the FDA refused to extend the indications of its asthma drug Nucala to include chronic obstructive pulmonary disorder (COPD). ... Another potentially strong challenge could come

Latest news

More from news
Approximately 60 fully matching, plus 487 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    up innate immune responses, and Cancer Research UK is repurposing an AZ chemokine CCR4 receptor drug (AZD2098) originally developed for asthma in kidney cancer.

  • Six degrees of participation Six degrees of participation

    individual. We can tell a GP in Hull that Joan in Stepney is not happy with her asthma care. ... If we know that Joan and others are unhappy with asthma services in Hull, let’s collaborate to determine what we can do to help.

  • The good, the bad and the ugly The good, the bad and the ugly

    Its revenues grew by a further 9% last year. “A large percentage of this growth was driven by Ellipta, but Nucala - a biologic approved for asthma and COPD - also played its

  • Integrating digital biomarkers into precision medicine Integrating digital biomarkers into precision medicine

    Such monitoring could also allow for early prediction of treatment success, eg in a study to evaluate asthma treatment outcomes.

  • Asthma: beyond the blue and the brown Asthma: beyond the blue and the brown

    Asthma is one of the most significant non-communicable diseases of the 21st century. ... The two professors led The Lancet Clinical Commission, ‘After asthma: redefining airways diseases’in 2015.

More from intelligence
Approximately 2 fully matching, plus 34 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Londonvelophobia (fear of cycling in London) – debunked

    Pollution in London drastically needs addressing and for people who suffer from asthma, have heart conditions or respiratory issues, it’ s still a serious concern, but getting more people cycling is

  • Irritable Bowel Syndrome (IBS) Patient Insights

    All of this adds up to create an environment in which societal awareness and open discussion of IBS is lacking when compared to other chronic illnesses such as asthma or

  • Telehealth Research

    Telehealth services are being used by more and more patients with chronic diseases such as asthma, COPD, diabetes and cardiovascular disease.

  • Raising Awareness: It’s World COPD Day today!

    7).The management of COPD could therefore be improved by limiting the use of ICS to the minority who might actually benefit; in particular COPD patients with asthma– COPD overlap syndrome ... Genetic background, clinical presentation, comorbidities,

  • Take a walk on the wild side!

    type 2 diabetes, asthma, stroke and some cancers.’ That’ s quite a list of benefits for something so simple!

More from PMHub
Approximately 1 fully matching, plus 22 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics